Irene

New CEO Appointed At €1.3bn Greek Loan Servicing Company Thea Artemis

Retrieved on: 
Sunday, July 16, 2023
Irene, NPL, AQR, Sale, Athens Exchange, Senior management, Growth, Management, Financial services, Bank, EU

ATHENS, Greece, July 16, 2023 /PRNewswire/ -- Mr. Konstantinos Kounadis has accepted the position of CEO of Thea Artemis S.A., a loan servicing company managing a €1.3 billion non-performing loan portfolio.

Key Points: 
  • ATHENS, Greece, July 16, 2023 /PRNewswire/ -- Mr. Konstantinos Kounadis has accepted the position of CEO of Thea Artemis S.A., a loan servicing company managing a €1.3 billion non-performing loan portfolio.
  • Mr. Kounadis looks to execute the Thea Artemis strategic plan which in the short term includes upgrading the servicer's technology, improving and expanding operations, and then growing the company's assets under management and customer base.
  • In the longer term the new CEO looks to expand the Thea Artemis offering to include real estate management and the servicing of performing loans.
  • Prior to accepting this position, Mr. Kounadis has a successful track record in several Senior Management and C-level positions.

New CEO Appointed At €1.3bn Greek Loan Servicing Company Thea Artemis

Retrieved on: 
Sunday, July 16, 2023
Irene, NPL, AQR, Sale, Athens Exchange, Senior management, Growth, Management, Financial services, Bank, EU

ATHENS, Greece, July 16, 2023 /PRNewswire/ -- Mr. Konstantinos Kounadis has accepted the position of CEO of Thea Artemis S.A., a loan servicing company managing a €1.3 billion non-performing loan portfolio.

Key Points: 
  • ATHENS, Greece, July 16, 2023 /PRNewswire/ -- Mr. Konstantinos Kounadis has accepted the position of CEO of Thea Artemis S.A., a loan servicing company managing a €1.3 billion non-performing loan portfolio.
  • Mr. Kounadis looks to execute the Thea Artemis strategic plan which in the short term includes upgrading the servicer's technology, improving and expanding operations, and then growing the company's assets under management and customer base.
  • In the longer term the new CEO looks to expand the Thea Artemis offering to include real estate management and the servicing of performing loans.
  • Prior to accepting this position, Mr. Kounadis has a successful track record in several Senior Management and C-level positions.

KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences

Retrieved on: 
Thursday, June 15, 2023
American Association of Nurse Practitioners, Bachelor of Pharmacy, Abstract, LSE, Endocrinology, American Diabetes Association, Doctor of Pharmacy, University, Nephrology, Type 2 diabetes, PDT, Emergency Pharmacy System, SALT, Assistant, Chicago, Patient, Division, Physician, Diabetic nephropathy, Risk, Motivation, Poster, DKD, American Association of Clinical Endocrinologists, Health, Mount Sinai Health System, CKD, Irene, AANP, Conference, Kidney disease, Medicine, D3M, Pharmaceutical industry, Medical device, Nursing, Policy

Accepted abstracts reflect the growing body of scientific evidence demonstrating the important role KidneyIntelX serves towards advancing patient care and awareness for early-stage diabetic kidney disease.

Key Points: 
  • Accepted abstracts reflect the growing body of scientific evidence demonstrating the important role KidneyIntelX serves towards advancing patient care and awareness for early-stage diabetic kidney disease.
  • The presentations at the American Diabetes Association 83rd Scientific Sessions meeting include late-breaking data from a multi-year real-world evidence study, extended validation of KidneyIntelX, and a cost-effectiveness analysis addressing economic benefit in the VA population.
  • American Diabetes Association 83rd Scientific Sessions presentations will be displayed over three days June 24-26, 2023, and moderated at the specified times below.
  • For more information about Renalytix hosted medical education events while at the 83rd Scientific Sessions of the American Diabetes Association, please email [email protected] .

Editas Medicine Announces Dosing of First Pediatric Patient in the BRILLIANCE Clinical Trial of EDIT-101 for LCA10

Retrieved on: 
Monday, April 11, 2022
Therapy, Adult, F.M. Kirby Center, Research, European Medicines Agency, CEO, Lists of diseases, MD, Center, Nasdaq, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, GLOBE, Annual report, CRISPR, University, Disease, Security (finance), LCA, Child, Retinal degeneration, U.S. Securities and Exchange Commission, Perelman School of Medicine at the University of Pennsylvania, Gene, B cell, EMA, Editas Medicine, Life, Irene, IDMC, Forward-looking statement, Clinical trial, Penn, CHOP, Penn Presbyterian Medical Center, Leber congenital amaurosis, NCT, Severe cognitive impairment, FDA, Patient, Company, Private Securities Litigation Reform Act, Pediatric ophthalmology, Degenerative disease, CEP290, Hospital, Incidence, Ophthalmology, Food, Safety, Gene editing, Eye, Division, Pharmaceutical industry

CAMBRIDGE, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced the administration of EDIT-101, an experimental CRISPR gene editing medicine, to the first pediatric patient enrolled in the BRILLIANCE clinical trial, which is designed to test the safety of EDIT-101 for the treatment of Leber congenital amaurosis 10 (LCA10), a CEP290-related retinal degenerative disorder. This marks the world’s first in vivo, or inside the body, dosing of a pediatric patient with a CRISPR gene editing experimental medicine.

Key Points: 
  • This marks the worlds first in vivo, or inside the body, dosing of a pediatric patient with a CRISPR gene editing experimental medicine.
  • Currently, there are no approved treatments for LCA10, and we look forward to sharing future updates from the BRILLIANCE trial, including sharing additional clinical data, later this year.
  • Enrolling this first pediatric patient in the BRILLIANCE trial is an important step toward bringing potentially life-changing treatments to children with genetic retinal diseases.
  • Previously, Editas Medicine completed dosing of all adult cohorts in its BRILLIANCE study and announced preliminary EDIT-101 clinical results demonstrated a favorable safety profile and encouraging signals of clinical benefit.

2021 Irene Adler Prize Goes to Isabella Goodman: Journalism Major Wins $1,000 Scholarship for Women Writers

Retrieved on: 
Tuesday, August 3, 2021
Given names, Adler, Irene, Names

VANCOUVER, BC, Aug. 3, 2021 /PRNewswire/ -- Isabella Goodman has won the 2021 Irene Adler Prize for her essay, "A Catalog in Friendship."

Key Points: 
  • VANCOUVER, BC, Aug. 3, 2021 /PRNewswire/ -- Isabella Goodman has won the 2021 Irene Adler Prize for her essay, "A Catalog in Friendship."
  • Founded in 2017, the annual Irene Adler Prize offers a $1,000 scholarship to a woman pursuing a degree in journalism, creative writing, or literature at a recognized post-secondary institution in the U.S. or Canada, based on an essay competition.
  • "Her evocative, textured prose stood out in what was undoubtedly the most competitive field of entries in Irene Adler Prize history."
  • For more on the Irene Adler Prize, the 2021 winning essay, and past winners, see:
    The 2022 Irene Adler Prize submission guidelines will be released in January.

EKC PR Client, Asian American Actress, Irene Tsu, Voices Nai Nai in the 2021 Oscars Best Animated Feature Nominee, Over the Moon

Retrieved on: 
Tuesday, April 20, 2021
Given names, Actors, Irene Tsu, Irene, Glen Keane, Nancy Kwan, Tsu, Women

b'LOS ANGELES, April 20, 2021 /PRNewswire/ --Barrier-breaking Asian American actress and author, Irene Tsu ,plays the role of Nai Nai, the calm and caring grandmain theNetflix Originals film, Over the Moon (2020).\nDirected by legendary animator Glen Keane andnominated for Best Animated Feature at this Sunday\'s Oscars,the filmis an empowering and heartwarming story about independence and imagination.

Key Points: 
  • b'LOS ANGELES, April 20, 2021 /PRNewswire/ --Barrier-breaking Asian American actress and author, Irene Tsu ,plays the role of Nai Nai, the calm and caring grandmain theNetflix Originals film, Over the Moon (2020).\nDirected by legendary animator Glen Keane andnominated for Best Animated Feature at this Sunday\'s Oscars,the filmis an empowering and heartwarming story about independence and imagination.
  • "That\'s why films focused on cultural inclusion, likeOver the Moon,are so important as it allows children to see their own culture and experiences reflected onscreen.
  • In 1957, her family emigrated to America and Irene attendedschool in New York where she studied ballet and trained for her dream.
  • About 15 years later she auditioned for her first Broadway show,Flower Drum Song, and subsequently got a part in the film adaption directed byHenry Kosterand starringNancy Kwan.\nWith a natural dexterity for acting, Irene began to pick up more substantial roles, eventually becoming a distinguished and sought-after Asian American actress.\n'

Eirene quickly expands across Ontario to provide online cremation arrangement services

Retrieved on: 
Thursday, January 21, 2021
Given names, Death customs, Fire, Cremation, Incineration, Eirene, Irene

TORONTO, Jan. 21, 2021 /PRNewswire-PRWeb/ -- Eirene.ca , an online cremation and end-of-life technology platform, today announced it is expanding its services across the province of Ontario.

Key Points: 
  • TORONTO, Jan. 21, 2021 /PRNewswire-PRWeb/ -- Eirene.ca , an online cremation and end-of-life technology platform, today announced it is expanding its services across the province of Ontario.
  • Eirene, which launched in November of last year in the Greater Toronto Area, is quickly growing to provide more Canadians with its simple, affordable and convenient cremation arrangement services.
  • "We built Eirene with a conviction that Canadians need a trusted partner and seamless online service to manage cremation arrangements for their loved-one's passing," said Mallory Greene, CEO, Eirene.
  • Founded in 2019, Eirene is Canada's first direct cremation technology platform making cremation easier and more affordable for clients.

Third Annual Irene Adler Prize Goes to Susan Purr: M.F.A. Candidate Wins $1,000 Scholarship for Women Writers

Retrieved on: 
Thursday, August 1, 2019
Adler, Irene, Fictional characters, Names, Humans

VANCOUVER, British Columbia, Aug. 1, 2019 /PRNewswire/ --Susan Purr has won the 2019 Irene Adler Prize for her essay"Spider Woman."

Key Points: 
  • VANCOUVER, British Columbia, Aug. 1, 2019 /PRNewswire/ --Susan Purr has won the 2019 Irene Adler Prize for her essay"Spider Woman."
  • The annual Irene Adler Prize offers a $1,000 scholarship to a woman pursuing a degree in journalism, creative writingor literature at a recognized post-secondary institution in the U.S. or Canada, based on an essay competition.
  • "It's a rewarding feeling to know that the Irene Adler Prize is helping to amplify their voices."
  • For more on the Irene Adler Prize and the winning essay, see http://lucasaykroyd.com/scholarships .

2018 Irene Adler Prize Awarded to Lynnette Curtis: M.F.A. Candidate Wins $1,000 Prize for Women Writers

Retrieved on: 
Wednesday, August 1, 2018
Film, Fiction, Literature, Sherlock Holmes, Irene Adler, A Scandal in Bohemia, Adler, Irene, A scandal in, Sherlock

VANCOUVER, British Columbia, Aug. 1, 2018 /PRNewswire/ -- Lynnette Curtis has won the 2018 Irene Adler Prize for her essay, "Letters to Las Vegas."

Key Points: 
  • VANCOUVER, British Columbia, Aug. 1, 2018 /PRNewswire/ -- Lynnette Curtis has won the 2018 Irene Adler Prize for her essay, "Letters to Las Vegas."
  • "Lynnette powerfully captures the impact of the recent Las Vegas mass shooting on her literary aspirations," said prize founder Lucas Aykroyd .
  • The Irene Adler Prize is named after the heroine of the 1891 Sherlock Holmes detective story "A Scandal in Bohemia" by Sir Arthur Conan Doyle.
  • For more on the Irene Adler Prize and the winning essay, see:
    The 2019 Irene Adler Prize submission guidelines will be released in January.